Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,192 public trials 151 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Active, Not Recruiting

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

NCT01782703

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Northwestern University Chicago, Illinois, United States
  • Northbrook Lurie Children's Outpatient Clinic Northbrook, Illinois, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating TRIV-509 in Atopic Dermatitis

NCT07167758

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Triveni Bio Site #11 Fountain Valley, California, United States
  • Triveni Bio Site #4 San Diego, California, United States
  • Triveni Bio Site #3 Miami, Florida, United States
  • Triveni Bio Site #6 Indianapolis, Indiana, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

NCT03952559

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Instituto de Neumonología Y Dermatología Capital Federal, Buenos Aires, Argentina
  • Centro de Investigaciones Metabólicas (CINME) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Fundacion CIDEA Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina
  • Fundación Respirar Buenos Aires, Argentina
View all 78 locations
View Trial Details
Active, Not Recruiting

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT05769777

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Allervie Clinical Research - Birmingham- Site Number : 8400050 Birmingham, Alabama, United States
  • Research Solutions of Arizona- Site Number : 8400020 Litchfield Park, Arizona, United States
  • Dermatology Trial Associates- Site Number : 8400027 Bryant, Arkansas, United States
  • University Dermatology Trials- Site Number : 8400052 Newport Beach, California, United States
View all 174 locations
View Trial Details
Active, Not Recruiting

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT06526182

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital del Mar - Parc de Salut Mar Barcelona, Spain
  • Hospital Universitario Clínico San Cecilio Granada, Spain
  • Consorci Hospital General Universitari de València Valencia, Spain
View Trial Details
Active, Not Recruiting

To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

NCT06552520

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Tongling People's Hospital Tongling, Anhui, China
  • The Second Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 73 locations
View Trial Details
Active, Not Recruiting

A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

NCT05983068

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • National Jewish Health Medical Center- Site Number : 8400001 Denver, Colorado, United States
  • SSM Health Saint Louis University Hospital- Site Number : 8400006 St Louis, Missouri, United States
  • NYU Langone Medical Center- Site Number : 8400004 New York, United States
  • Investigational Site Number : 8260001 Sheffield, United Kingdom
View Trial Details
Active, Not Recruiting

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

NCT07011706

Conditions
AD, Atopic, Atopic Dermatitis, +12 more
Locations
  • Aclaris Clinical Site Phoenix, Arizona, United States
  • Aclaris Clinical Site Tucson, Arizona, United States
  • Aclaris Study Site Bryant, Arkansas, United States
  • Aclaris Clinical Site Beverly Hills, California, United States
View all 60 locations
View Trial Details
Active, Not Recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details

Related conditions